Physician profile
Amy L Couch
NPI 1275730152
$41,886.16
in general payments reported to CMS, 2019-2025
25 companies · $2,020 in 2025
The $2,020 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $1,579 · 2023: $12K · 2024: $26K · 2025: $2,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $12K · Travel and Lodging: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,962.03 |
| Food and Beverage | $12,365.54 |
| Travel and Lodging | $841.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $28,912.77 | 2023-2025 | Miro3d, Miro3d Fibers, Miroderm |
| Imbed Biosciences INC. | $4,447.21 | 2023 | |
| Ets Wound Care LLC | $1,941.12 | 2022-2025 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $1,272.03 | 2022-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Organogenesis INC. | $1,263.95 | 2021-2025 | Puraply, Puraply Wound Matrix, Nushield |
| Integra Lifesciences Corporation | $771.88 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nuo Therapeutics | $612.03 | 2023-2024 | |
| Koya Medical, INC. | $603.91 | 2022-2025 | Dayspring, Koya Medical, Dayspring |
| Kerecis Limited | $343.86 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Next Science LLC | $304.11 | 2023 | Xperience, Blastx, Surgx |
| Convatec INC. | $300.93 | 2022-2025 | |
| Hydrofera LLC | $292.34 | 2023-2025 | Hydrofera Blue |
| Tactile Systems Technology INC | $174.35 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $129.36 | 2023-2025 | Dalvance |
| Hartmann USA, INC. | $120.52 | 2023-2025 | Zetuvit Plus 10x10 P10, Zetuvit Plus |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $74.08 | 2024 | |
| Cook Medical LLC | $60.81 | 2025 | Zilver Ptx |
| Solventum Corporation | $53.52 | 2025 | Prevena, 3m Coban, 3m Cavilon |
| Elite Orthopedics, LLC | $53.14 | 2024 | |
| Progenacare Global, LLC | $42.28 | 2023 | |
| Prytime Medical Devices, INC. | $31.90 | 2024 | Er-Reboa Plus |
| Otsuka America Pharmaceutical, INC. | $23.57 | 2025 | Rexulti |
| Kci USA, INC. | $21.71 | 2021 | |
| Sanara Medtech INC. | $20.28 | 2023 | Celleraterx |
| Acera Surgical, INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.